DaVita Inc. (DVA) Stock Price

DVAStock

$177.80+25.75%52W

Market Cap$11.34B

P/E15.48x

PEG Ratio0.55

Div yield—

Beta0.81

DVA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)8.21%

Price vs S&P 500 (4W)-29.34%

PEG Ratio0.55

VGM Score50.07

P/E Ratio (Annual)15.48x

P/CF (Annual)6.13x

Book Value / Share (Quarterly)$1.50

P/TBV (Annual)11.21x

Revenue Growth (3Y)5.53%

Cash Flow / Share (Quarterly)$25.17

Price vs S&P 500 (YTD)43.40%

Gross Margin (TTM)32.36%

Net Profit Margin (TTM)6.05%

EPS (TTM)$12.21

10-Day Avg Trading Volume0.71M

EPS Excl Extra (TTM)$12.21

Revenue Growth (5Y)3.39%

EPS (Annual)$9.84

ROI (Annual)9.79%

Gross Margin (Annual)32.25%

Net Profit Margin (5Y Avg)6.34%

Cash / Share (Quarterly)$10.77

P/E Basic Excl Extra (TTM)13.64x

Revenue Growth QoQ (YoY)5.17%

EPS Growth (5Y)9.36%

P/E Normalized (Annual)15.48x

ROA (Last FY)4.27%

Revenue Growth TTM (YoY)6.45%

EBITD / Share (TTM)$40.31

ROE (5Y Avg)220.50%

Operating Margin (TTM)15.07%

Cash Flow / Share (Annual)$19.12

P/B Ratio95.43x

P/B Ratio (Quarterly)101.25x

Net Income / Employee (Annual)$9,600

EV / Revenue (TTM)1.55x

Net Interest Coverage (TTM)3.46x

ROA (TTM)4.83%

EPS Growth QoQ (YoY)55.84%

EV / EBITDA (TTM)7.68x

EPS Incl Extra (Annual)$9.84

Current Ratio (Annual)1.29x

Quick Ratio (Quarterly)1.36x

3-Month Avg Trading Volume0.88M

52-Week Price Return25.75%

EV / Free Cash Flow (Annual)16.53x

P/E Incl Extra (TTM)13.64x

Revenue / Employee (TTM)$179,600

Tangible BV / Share (Quarterly)$2.29

P/S Ratio (Annual)0.85x

Asset Turnover (Annual)0.78x

52-Week High$247.49

Operating Margin (5Y Avg)14.24%

EPS Excl Extra (Annual)$9.84

CapEx CAGR (5Y)-3.11%

Tangible BV CAGR (5Y)-24.96%

26-Week Price Return19.46%

Quick Ratio (Annual)1.19x

13-Week Price Return-11.15%

Total Debt / Equity (Annual)77.99x

Current Ratio (Quarterly)1.47x

Enterprise Value$21.67B

Revenue / Share Growth (5Y)13.87%

Asset Turnover (TTM)0.80x

Book Value / Share Growth (5Y)-38.38%

Revenue / Employee (Annual)$174,900

Inventory Turnover (Annual)62.63x

Pretax Margin (Annual)9.87%

Cash / Share (Annual)$10.22

3-Month Return Std Dev42.29%

Gross Margin (5Y Avg)31.46%

Net Income / Employee (TTM)$10,900

EBITDA CAGR (5Y)4.19%

EBITDA Interim CAGR (5Y)2.44%

ROE (Last FY)773.06%

Net Interest Coverage (Annual)3.63x

EPS Basic Excl Extra (Annual)$9.84

P/FCF (TTM)7.18x

Receivables Turnover (TTM)5.71x

EV / Free Cash Flow (TTM)13.46x

Total Debt / Equity (Quarterly)77.99x

EPS Incl Extra (TTM)$12.21

Receivables Turnover (Annual)5.37x

ROI (TTM)9.56%

P/S Ratio (TTM)0.82x

Pretax Margin (5Y Avg)10.58%

Revenue / Share (Annual)$179.79

Tangible BV / Share (Annual)$9.60

Forward P/E11.98x

Free OCF CAGR (5Y)0.09%

Price vs S&P 500 (52W)7.44%

P/E Ratio (TTM)13.64x

EPS Growth TTM (YoY)19.98%

Year-to-Date Return55.36%

5-Day Price Return-0.79%

EPS Normalized (Annual)$9.84

ROA (5Y Avg)4.56%

Net Profit Margin (Annual)5.47%

Month-to-Date Return-26.49%

Cash Flow / Share (TTM)$17.04

EBITD / Share (Annual)$36.17

EPS Growth (3Y)19.05%

Operating Margin (Annual)14.88%

LT Debt / Equity (Annual)75.76x

P/CF (TTM)5.27x

ROI (5Y Avg)8.24%

P/E Excl Extra (TTM)13.64x

LT Debt / Equity (Quarterly)75.76x

EPS Basic Excl Extra (TTM)$12.21

P/TBV (Quarterly)71.72x

P/B Ratio (Annual)101.25x

Inventory Turnover (TTM)63.64x

Pretax Margin (TTM)10.48%

Book Value / Share (Annual)$1.50

Price vs S&P 500 (13W)-13.95%

Net Margin Growth (5Y)-3.98%

Beta0.81x

P/FCF (Annual)8.82x

Revenue / Share (TTM)$211.97

ROE (TTM)181.22%

52-Week Low$101.00

vGradeB

gGradeC

mGradeC

vgmGradeC

DVA Earnings Surprise History

Q2 252.95est. 2.75

Q3 252.51est. 3.17

Q4 253.40est. 3.19

Q1 262.87est. 2.33

Q2 264.02est. 3.88

DVA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.43

3.50

3.46

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	Price
DVADaVita Inc.	B	C	C	$177.80
FMSFresenius Medical Care AG	A	D	D	$23.51
SHCSotera Health Company Common Stock	D	B	B	$19.51
PGNYProgyny, Inc. Common Stock	C	B	C	$25.82
AGLagilon health, inc.	B	B	B	$96.11
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	$9.10
PARKPark Dental Partners, Inc. Common Stock	B	C	C	$20.46
CCELCryo-Cell International Inc.	C	D	B	$4.30
MGRXMangoceuticals, Inc. Common Stock	D	F	D	$0.39
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	D	D	D	$0.22
NIVFNewGenIvf Group Limited Class A ordinary shares	A	B	F	$0.55
NIVFWNewGenIvf Group Limited Warrants	—	—	D	$0.02
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	C	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	C	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	C	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	$0.00

About DaVita Inc.

DaVita is the largest U.S. dialysis provider, operating over 3,000 facilities globally and treating approximately 280,000 patients annually, with roughly 35% of U.S. market share. The company derives about two-thirds of U.S. sales from government payers (primarily Medicare) at regulated reimbursement rates. Though commercial insurers represent only 10% of U.S. patients served, they generate nearly all profits from the U.S. dialysis business, creating significant earnings sensitivity to commercial payer mix.